Willow Biosciences Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was CAD 5.840 million compared to CAD 9.285 million a year ago. Net income was CAD 6.523 million compared to net loss of CAD 10.069 million a year ago. Basic earnings per share from continuing operations was CAD 0.05 compared to basic loss per share from continuing operations of CAD 0.13 a year ago. For the half year, operating loss was CAD 10.620 million compared to CAD 13.873 million a year ago. Net loss was CAD 4.782 million compared to CAD 11.485 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.15 a year ago.